Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis.
about
Posaconazole: clinical pharmacology and potential for management of fungal infections.Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.Posaconazole: a new broad-spectrum antifungal agent.Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.Immunomodulatory properties of antifungal agents on phagocytic cells.Modulating host immune responses to fight invasive fungal infections.
P2860
Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effect of granulocyte colony-s ...... urine pulmonary aspergillosis.
@en
type
label
Effect of granulocyte colony-s ...... urine pulmonary aspergillosis.
@en
prefLabel
Effect of granulocyte colony-s ...... urine pulmonary aspergillosis.
@en
P2093
P2860
P1476
Effect of granulocyte colony-s ...... urine pulmonary aspergillosis.
@en
P2093
Andriani C Patera
Anthony Cacciapuoti
David Loebenberg
Frederick Menzel
Joan K Brieland
Judy Halpern
Roberta Hare
P2860
P304
P356
10.1128/AAC.48.8.3154-3158.2004
P407
P50
P577
2004-08-01T00:00:00Z